$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
全球首款每日1片三联丙肝新药吉四代在中国获批上市
2025-10-19 11:44:20
Check Details
今天带大家了解一下吉四代的使用方法和副作用
2025-10-19 11:44:20
Check Details
吉四代国内完成获批,被纳入医保了吗?
2025-10-19 11:44:20
Check Details
格卡瑞韦/哌仑他韦治疗慢性丙型肝炎亚裔患者
2025-10-19 11:44:20
Check Details
实现治愈丙肝的丙通沙究竟好在哪?
2025-10-19 11:44:20
Check Details
吉一代优势有哪些?
2025-10-19 11:44:20
Check Details
吉一代治疗期间,患者生活中也需要注意一些事项
2025-10-19 11:44:20
Check Details
MyHepAll的副作用有什么?
2025-10-19 11:44:20
Check Details
服用吉四代的不良反应大吗?吉四代不良反应怎么处理?
2025-10-19 11:44:20
Check Details
吉三代的最常见不良反应
2025-10-19 11:44:20
Check Details
吉四代(沃士韦)作用功效是什么?不良反应很多吗
2025-10-19 11:44:20
Check Details
服用丙通沙后胃疼正常吗
2025-10-19 11:44:20
Check Details
1
2
...
6067
6068
6069
6070
6071
6072
6073
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
2
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
3
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
4
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
5
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
6
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
7
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
8
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
9
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
10
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
11
Daraxonrasib Pregnancy, Lactation and Contraception Safety
12
Afatinib Side Effects and Safety Management